About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2529 blog entries.

New York

On May 5, NYRx issued a notice NYRx Helpful Hints for Pharmacies: Diabetic Testing Supplies 

Diabetic Test Strips and Lancets: NYRx coverage of preferred blood glucose test strips and lancets for members with diabetes aligns with Medicare Coverage of Diabetes Supplies.  

Pharmacies must submit claims based on units per days' supply as follows:  

  • Members who use insulin: Maximum 300 test strips and lancets per 90-day supply    
  • Members who do not use insulin: Maximum 100 test strips and lancets per 90-day supply   

Continuous Glucose Monitors and Disposable Insulin Pumps: Continuous Glucose Monitors and Disposable Insulin Pumps should be billed at the pharmacy point-of-sale for the proper quantity and days' supply as outlined on the product label.  

What Pharmacies Need to Do: The pharmacy should become familiar with the NYRx Preferred Diabetic Supply Program. When submitting claims for preferred diabetic supplies do not request a PA (prior authorization) from the prescriber if the claim rejection states one of the following:  

  • Maximum Quantity Exceeded  
  • Early Fill Overuse  
  • Recipient Ineligible on Service Date  
  • Refill Number Exceeds Maximum  
  • Therapeutic Duplication  
  • Client Has Medicare Part D or Client Has Other Insurance  
  • Coordination of Benefits Claim Processing  
  • NYRx is always the payor of last resort and federal regulations require that all other available resources be used before NYRx considers payment.   

 The NYRx Education & Outreach Call Center is available by phone at 1-833-967-7310 or by email at NYRxEO@primetherapeutics.com from 8:00 am to 5:00 pm ET, Monday through Friday, excluding holidays. 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2025-05-08T14:03:15-04:00May 8, 2025|New York|

Oregon

The Board of Pharmacy announced the agency’s new director, Dr. Gary Runyon, PharmD, a graduate of the University of Tennessee College of Pharmacy. Gary brings over 22 years of diverse pharmacy experience to Oregon, where he relocated in late 2020. Gary joined the Board of Pharmacy as a Compliance Officer, then transitioned to the Pharmacist Consultant position before becoming Executive Director effective April 14.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-05-08T14:02:23-04:00May 8, 2025|Oregon|

South Carolina

NACDS submitted comments to the Senate Banking and Insurance Committee ahead of its hearing on SB 342, which includes several NACDS priorities related to reimbursement reform. As this marks the first session of a two-year legislative term, NACDS expects to continue advocating for this and related legislation throughout the summer and fall in preparation for the 2026 session.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-01-15T07:23:45-05:00May 8, 2025|South Carolina|

Virginia

Virginia Pharmacies had a remarkable win in Virginia, when Gov. Governor Glenn Youngkin (R) signed our Medicaid PBM reform bill, HB 2610, after initially vetoing it and replacing it with a study. NACDS and VACDS were present on the ground in Richmond throughout the process, working with members and partners to pull every lever to secure a final victoryT NACDS issued a press release to praise Gov. Youngkin’s signature, and the legislature’s willpower, that led to the enactment of Virginia’s “single PBM” bill.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-05-08T14:01:19-04:00May 8, 2025|Virginia|

Arizona

Gov. Katie Hobbs (D) signed HB 2628 (Chapter 32), legislation permitting pharmacists to order and administer emergency medication to manage an acute allergic reaction to a medication administered at the pharmacy.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-04-03T14:33:24-04:00April 3, 2025|Arizona|

California

The Board of Pharmacy posted information for the following meetings: 

  • The Legislation and Regulation Committee Meeting will be held on April 9 beginning at 9:00 am Pacific. For details, please review the agenda. 
  • The Full Board Meeting will be held April 9-10 beginning at 1:00 pm Pacific on April 9. For details, please review the agenda. 

Also in California, the Department of Health Care Service posted the following weekly notices, alerts, and monthly bulletin on the Medi-Cal Rx Web Portal. Please note effective April 25, Medi-Cal Rx will complete implementation of Pediatric Integration by reinstating Reject Code 75 – Prior Authorization Required for all continuation of therapy claims for members 21 years of age and younger; see alert below for details. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-04-03T14:32:53-04:00April 3, 2025|California|

Idaho

Alex Adams, former executive director of the Board of Pharmacy, has been tapped to serve as the US Department of Health and Human Services assistant secretary for family support. The US Senate, which confirms presidential nominations, received his nomination. The State Legislature introduced a House Joint Memorial No. 8 to honor his work in the state.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-04-03T14:31:58-04:00April 3, 2025|Idaho|

Indiana

The Family and Social Services Administration (FSSA) issued Bulletin202538 providing updates to the Point-of-Sale Quick Check (PSQC) automated prior authorization (PA) system, PA criteria, mental health utilization edits, Statewide Uniform Preferred Drug List (SUPDL) and Preferred Brand Drug List.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-04-03T14:31:19-04:00April 3, 2025|Indiana|
Go to Top